Next Article in Journal
Neuronal Activity and Its Role in Controlling Antioxidant Genes
Next Article in Special Issue
Nanoparticles Modified with Cell-Penetrating Peptides: Conjugation Mechanisms, Physicochemical Properties, and Application in Cancer Diagnosis and Therapy
Previous Article in Journal
Endocrine Disruptors in Water and Their Effects on the Reproductive System
Previous Article in Special Issue
Inhibition of FGFR2-Signaling Attenuates a Homology-Mediated DNA Repair in GIST and Sensitizes Them to DNA-Topoisomerase II Inhibitors
Article

In Vitro Biophysical and Biological Characterization of Lipid Nanoparticles Co-Encapsulating Oncosuppressors miR-199b-5p and miR-204-5p as Potentiators of Target Therapy in Metastatic Melanoma

1
Istituto Nazionale Tumori IRCCS, "Fondazione G. Pascale", 80131 Naples, Italy
2
Department of Pharmacy, University of Naples Federico II, 80131 Naples, Italy
3
IRCCS, Istituto Nazionale Tumori “Regina Elena”, Via Elio Chianesi 53, 00144 Rome, Italy
4
Department of Molecular and Clinical Medicine, University of Roma “Sapienza”, 00185 Rome, Italy
*
Author to whom correspondence should be addressed.
These two authors contributed equally.
Int. J. Mol. Sci. 2020, 21(6), 1930; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21061930
Received: 6 February 2020 / Revised: 6 March 2020 / Accepted: 10 March 2020 / Published: 12 March 2020
Uncontrolled MAPK signaling is the main oncogenic driver in metastatic melanomas bearing mutations in BRAF kinase. These tumors are currently treated with the combination of BRAF/MEK inhibitors (MAPKi), but this therapy is plagued by drug resistance. In this context we recently discovered that several microRNAs are involved in the development of drug resistance. In particular miR-204-5p and miR-199b-5p were found to function as antagonists of resistance because their enforced overexpression is able to inhibit melanoma cell growth in vitro either alone or in combination with MAPKi. However, the use of miRNAs in therapy is hampered by their rapid degradation in serum and biological fluids, as well as by the poor intracellular uptake. Here, we developed lipid nanoparticles (LNPs) encapsulating miR-204-5p, miR-199b-5p individually or in combination. We obtained LNPs with mean diameters < 200 nm and high miRNA encapsulation efficiency. These formulations were tested in vitro on several melanoma cell lines sensitive to MAPKi or rendered drug resistant. Our results show that LNPs encapsulating combinations of the two oncosuppressor miRNAs are highly efficient in impairing melanoma cell proliferation and viability, affect key signaling pathways involved in melanoma cell survival, and potentiate the efficacy of drugs inhibiting BRAF and MEK. These results warrant further assessment of the anti-tumor efficacy of oncosuppressor miRNAs encapsulating LNPs in in vivo tumor models. View Full-Text
Keywords: Melanoma; nanoparticles; miRNAs; therapeutics; drug resistance Melanoma; nanoparticles; miRNAs; therapeutics; drug resistance
Show Figures

Figure 1

MDPI and ACS Style

Fattore, L.; Campani, V.; Ruggiero, C.F.; Salvati, V.; Liguoro, D.; Scotti, L.; Botti, G.; Ascierto, P.A.; Mancini, R.; De Rosa, G.; Ciliberto, G. In Vitro Biophysical and Biological Characterization of Lipid Nanoparticles Co-Encapsulating Oncosuppressors miR-199b-5p and miR-204-5p as Potentiators of Target Therapy in Metastatic Melanoma. Int. J. Mol. Sci. 2020, 21, 1930. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21061930

AMA Style

Fattore L, Campani V, Ruggiero CF, Salvati V, Liguoro D, Scotti L, Botti G, Ascierto PA, Mancini R, De Rosa G, Ciliberto G. In Vitro Biophysical and Biological Characterization of Lipid Nanoparticles Co-Encapsulating Oncosuppressors miR-199b-5p and miR-204-5p as Potentiators of Target Therapy in Metastatic Melanoma. International Journal of Molecular Sciences. 2020; 21(6):1930. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21061930

Chicago/Turabian Style

Fattore, Luigi, Virginia Campani, Ciro F. Ruggiero, Valentina Salvati, Domenico Liguoro, Lorena Scotti, Gerardo Botti, Paolo A. Ascierto, Rita Mancini, Giuseppe De Rosa, and Gennaro Ciliberto. 2020. "In Vitro Biophysical and Biological Characterization of Lipid Nanoparticles Co-Encapsulating Oncosuppressors miR-199b-5p and miR-204-5p as Potentiators of Target Therapy in Metastatic Melanoma" International Journal of Molecular Sciences 21, no. 6: 1930. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21061930

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop